Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-05-15

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$2.7bn reported value +32.3% vs Q4 2025
33positions
72.1%in top 10
8 new 6 added 6 reduced 2 sold out vs Q4 2025

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $714.9m26.68% 26.68% UnchangedShares held: Q2 2025 8.5m, Q3 2025 8.5m, Q4 2025 8.5m, Q1 2026 8.5m
2 ERASCA INC COM ERAS ERAS 16,382,812 $265.1m9.89% 9.89% ReducedShares held: Q2 2025 17.9m, Q3 2025 17.9m, Q4 2025 17.9m, Q1 2026 16.4m -1.5m -1,474,271 -8.3%
3 ORUKA THERAPEUTICS INC COM ORKA ORKA 4,148,428 $203.5m7.60% 7.60% UnchangedShares held: Q2 2025 4.1m, Q3 2025 4.1m, Q4 2025 4.1m, Q1 2026 4.1m
4 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 3,685,448 $185.9m6.94% 6.94% UnchangedShares held: Q2 2025 2.7m, Q3 2025 2.7m, Q4 2025 3.7m, Q1 2026 3.7m
5 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,474,485 $130.3m4.86% 4.86% ReducedShares held: Q2 2025 6.7m, Q3 2025 6.7m, Q4 2025 6.7m, Q1 2026 6.5m -254.5k -254,500 -3.8%
6 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,180,000 $99.0m3.70% 3.70% AddedShares held: Q2 2025 1.0m, Q3 2025 960.8k, Q4 2025 1.0m, Q1 2026 1.2m +180.0k +180,000 18.0%
7 DAMORA THERAPEUTICS INC COM NEW COM NEW 3,603,595 $93.3m3.48% 3.48% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 3.6m
8 OCULAR THERAPEUTIX INC COM OCUL OCUL 10,346,926 $87.6m3.27% 3.27% AddedShares held: Q2 2025 12.8m, Q3 2025 13.2m, Q4 2025 7.3m, Q1 2026 10.3m +3.0m +3,031,379 41.4%
9 COGENT BIOSCIENCES INC COM COGT COGT 2,000,000 $77.0m2.87% 2.87% UnchangedShares held: Q2 2025 4.8m, Q3 2025 4.0m, Q4 2025 2.0m, Q1 2026 2.0m
10 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $75.9m2.83% 2.83% UnchangedShares held: Q2 2025 3.9m, Q3 2025 3.9m, Q4 2025 3.9m, Q1 2026 3.9m
11 SAVARA INC COM SVRA SVRA 13,740,375 $75.0m2.80% 2.80% UnchangedShares held: Q2 2025 8.9m, Q3 2025 12.7m, Q4 2025 13.7m, Q1 2026 13.7m
12 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 1,726,331 $67.7m2.53% 2.53% ReducedShares held: Q2 2025 4.0m, Q3 2025 3.2m, Q4 2025 3.2m, Q1 2026 1.7m -1.5m -1,500,000 -46.5%
13 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,319,765 $54.7m2.04% 2.04% ReducedShares held: Q2 2025 6.6m, Q3 2025 6.6m, Q4 2025 5.7m, Q1 2026 4.3m -1.4m -1,356,465 -23.9%
14 VOR BIOPHARMA INC COM NEW VOR VOR 3,041,719 $54.3m2.03% 2.03% AddedShares held: Q2 2025 0, Q3 2025 500.0k, Q4 2025 1.9m, Q1 2026 3.0m +1.1m +1,097,953 56.5%
15 MAZE THERAPEUTICS INC COM MAZE MAZE 1,602,034 $47.8m1.78% 1.78% AddedShares held: Q2 2025 0, Q3 2025 1.2m, Q4 2025 1.5m, Q1 2026 1.6m +53.5k +53,465 3.5%
16 CYTOMX THERAPEUTICS INC COM CTMX CTMX 9,982,124 $46.9m1.75% 1.75% ReducedShares held: Q2 2025 14.0m, Q3 2025 15.6m, Q4 2025 15.6m, Q1 2026 10.0m -5.6m -5,579,376 -35.9%
17 JADE BIOSCIENCES INC COM NEW JBIO JBIO 3,220,364 $45.2m1.69% 1.69% UnchangedShares held: Q2 2025 3.2m, Q3 2025 3.2m, Q4 2025 3.2m, Q1 2026 3.2m
18 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $39.4m1.47% 1.47% UnchangedShares held: Q2 2025 2.2m, Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.2m
19 CRESCENT BIOPHARMA INC. COM CBIO CBIO 2,133,576 $39.2m1.46% 1.46% UnchangedShares held: Q2 2025 1.4m, Q3 2025 1.4m, Q4 2025 2.1m, Q1 2026 2.1m
20 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 6,434,990 $38.3m1.43% 1.43% AddedShares held: Q2 2025 4.6m, Q3 2025 4.6m, Q4 2025 5.3m, Q1 2026 6.4m +1.1m +1,089,875 20.4%
21 RELMADA THERAPEUTICS INC COM RLMD RLMD 4,843,380 $33.7m1.26% 1.26% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 4.8m
22 ENGENE HOLDINGS INC COM COM 4,771,414 $32.5m1.21% 1.21% UnchangedShares held: Q2 2025 5.0m, Q3 2025 5.0m, Q4 2025 4.8m, Q1 2026 4.8m
23 TENAX THERAPEUTICS INC COM NEW TENX TENX 1,675,262 $26.8m1.00% 1.00% NewShares held: Q2 2025 98.6k, Q3 2025 437.7k, Q4 2025 0, Q1 2026 1.7m
24 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 3,212,731 $22.2m0.83% 0.83% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 3.2m
25 CENTURY THERAPEUTICS INC COM IPSC IPSC 8,695,652 $19.7m0.73% 0.73% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 8.7m
26 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $19.6m0.73% 0.73% UnchangedShares held: Q2 2025 1.4m, Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.4m
27 CYBIN INC COM NEW COM NEW 3,851,654 $18.5m0.69% 0.69% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 3.8m, Q1 2026 3.9m +11.4k +11,404 0.3%
28 SURROZEN INC COM NEW SRZN SRZN 632,931 $18.4m0.69% 0.69% UnchangedShares held: Q2 2025 632.9k, Q3 2025 632.9k, Q4 2025 632.9k, Q1 2026 632.9k
29 SEPTERNA INC COM SEPN SEPN 506,056 $12.2m0.45% 0.45% ReducedShares held: Q2 2025 540.5k, Q3 2025 610.8k, Q4 2025 610.8k, Q1 2026 506.1k -104.8k -104,752 -17.1%
30 KORRO BIO INC COM KRRO KRRO 1,009,500 $11.4m0.43% 0.43% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 1.0m
31 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 500,000 $11.2m0.42% 0.42% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 500.0k
32 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $10.4m0.39% 0.39% UnchangedShares held: Q2 2025 1.6m, Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.6m
33 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 330,525 $1.4m0.05% 0.05% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 330.5k

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
UPSTREAM BIO INC UPB UPB 1,169,298 $31.7m1.2m shares
CASI PHARMACEUTICALS INC CASIF CASIF 987,259 $839.2k987.3k shares